Position in LXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,280
+$30,744 QoQ
Shares Held
22,200
-6.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 148 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. LXRX ranks #203 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in LXRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,280 | 22,200 | Shares | Defined | 2026-08-14 | |
| 2025-06-30 | $22,536 | 23,723 | Shares | Defined | 2025-08-14 | |
| 2023-12-31 | $549,591 | 359,210 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $854,692 | 784,122 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,779,431 | 1,213,726 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,146,621 | 2,940,997 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,878,928 | 3,077,973 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,305,544 | 3,043,977 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,004,213 | 3,228,072 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,747,990 | 3,228,704 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,065,205 | 2,808,428 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,469,190 | 3,216,048 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,617,130 | 3,402,425 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,648,812 | 3,006,612 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,135,510 | 1,794,009 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,391,914 | 966,607 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,638,302 | 1,319,151 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $999,202 | 512,412 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||